Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · IEX Real-Time Price · USD
2.560
-0.090 (-3.40%)
At close: Jul 19, 2024, 4:00 PM
2.640
+0.080 (3.13%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $91.19 million as of July 22, 2024.
Market Cap
91.19M
Enterprise Value
64.84M
1-Year Change
n/a
Ranking
Category
Stock Price
Market Cap Chart
Since April 5, 2024, Eupraxia Pharmaceuticals's market cap has increased from $80.50M to $91.19M, an increase of 13.28%. That is a compound annual growth rate of 54.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 91.20M | 13.29% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 94.07M |
| 111, Inc. | 93.71M |
| Assembly Biosciences | 93.29M |
| Asensus Surgical | 92.55M |
| LakeShore Biopharma | 92.26M |
| Cellectar Biosciences | 90.34M |
| Eton Pharmaceuticals | 89.92M |
| InflaRx | 89.50M |